Chemotherapy-Induced Neutropenia and Emerging Agents for Prevention and Treatment: A Review
Cette étude passe en revue les différents agents, anciens et émergents, utilisés pour prévenir et traiter une neutropénie induite par la chimiothérapie chez des patients atteints d'un cancer
Chemotherapy-induced neutropenia can lead to poor clinical outcomes.
CIN can lead to infections, hospitalizations, mortality, and lower chemotherapy doseintensity.
G-CSF agents have been the standard of care for the prevention of CIN for 30 years.
Emerging therapies will likely change the standard approach for CIN prevention.
Cancer Treatment Reviews , résumé, 2021